发明名称 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸
摘要 <p>The present disclosure relates to lipid compounds of the general formula (I): R1—O—C(R2)(R3)—X  (I) wherein R1 is a C10-C22 alkyl group, a C10-C22 alkenyl group having 1-6 double bonds, or a C10-C22 alkynyl group having 1-6 triple bonds; R2 and R3 are the same or different and may be chosen from different substituents; and X is a carboxylic acid or a derivative thereof, such as a carboxylic ester, a carboxylic anhydride, a phospholipid, triglyceride, or a carboxamide; or a pharmaceutically acceptable salt, solvate, solvate of such salt, or a prodrug thereof. The present disclosure also relates to pharmaceutical compositions and lipid compositions comprising at least one compound according to the present disclosure, and to such compounds for use as medicaments or for use in therapy, in particular for the treatment of diseases related to the cardiovascular, metabolic, and inflammatory disease area.</p>
申请公布号 JP5843755(B2) 申请公布日期 2016.01.13
申请号 JP20120509111 申请日期 2010.05.07
申请人 プロノヴァ・バイオファーマ・ノルゲ・アーエスPronova BioPharma Norge AS 发明人 ホヴランド,ラグナー;ホルマイデ,アン,クリスティン;スキレ,トレ;ブレンドヴァン,モルテン
分类号 C07C59/60;A61K31/19;A61P3/06;A61P3/10;A61P9/10;A61P29/00;C07C51/367 主分类号 C07C59/60
代理机构 代理人
主权项
地址